vs
CPI AEROSTRUCTURES INC（CVU）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是CPI AEROSTRUCTURES INC的1.0倍（$19.6M vs $19.4M），CPI AEROSTRUCTURES INC净利率更高（3.6% vs -177.4%，领先181.0%），CPI AEROSTRUCTURES INC同比增速更快（-10.8% vs -11.5%），CPI AEROSTRUCTURES INC自由现金流更多（$-2.1M vs $-23.1M），过去两年CPI AEROSTRUCTURES INC的营收复合增速更高（0.9% vs -12.2%）
CPI航空结构公司（简称CPI Aero）总部位于美国纽约州埃德伍德国，是一家专业承接定制订单的飞机零部件制造商，专注为航空领域客户供应航空结构组件。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CVU vs LAB — 直观对比
营收规模更大
LAB
是对方的1.0倍
$19.4M
营收增速更快
CVU
高出0.7%
-11.5%
净利率更高
CVU
高出181.0%
-177.4%
自由现金流更多
CVU
多$21.0M
$-23.1M
两年增速更快
CVU
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.4M | $19.6M |
| 净利润 | $691.8K | $-34.7M |
| 毛利率 | 20.3% | 48.5% |
| 营业利润率 | 6.4% | -168.5% |
| 净利率 | 3.6% | -177.4% |
| 营收同比 | -10.8% | -11.5% |
| 净利润同比 | -28.8% | -28.8% |
| 每股收益（稀释后） | $0.04 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVULAB
| Q4 25 | $19.4M | — | ||
| Q3 25 | $19.3M | $19.6M | ||
| Q2 25 | $15.2M | $21.8M | ||
| Q1 25 | $15.4M | $40.8M | ||
| Q4 24 | $21.8M | — | ||
| Q3 24 | $19.4M | $22.1M | ||
| Q2 24 | $20.8M | $22.5M | ||
| Q1 24 | $19.1M | $45.5M |
净利润CVULAB
| Q4 25 | $691.8K | — | ||
| Q3 25 | $1.1M | $-34.7M | ||
| Q2 25 | $-1.3M | $-33.5M | ||
| Q1 25 | $-1.3M | $-26.0M | ||
| Q4 24 | $971.5K | — | ||
| Q3 24 | $749.7K | $-26.9M | ||
| Q2 24 | $1.4M | $-45.7M | ||
| Q1 24 | $168.2K | $-32.2M |
毛利率CVULAB
| Q4 25 | 20.3% | — | ||
| Q3 25 | 22.3% | 48.5% | ||
| Q2 25 | 4.4% | 48.8% | ||
| Q1 25 | 10.7% | 48.4% | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 21.7% | 54.9% | ||
| Q2 24 | 24.6% | 46.1% | ||
| Q1 24 | 18.6% | 53.1% |
营业利润率CVULAB
| Q4 25 | 6.4% | — | ||
| Q3 25 | 9.1% | -168.5% | ||
| Q2 25 | -13.1% | -118.1% | ||
| Q1 25 | -7.7% | -80.8% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 7.6% | -120.9% | ||
| Q2 24 | 11.2% | -134.5% | ||
| Q1 24 | 4.4% | -132.2% |
净利率CVULAB
| Q4 25 | 3.6% | — | ||
| Q3 25 | 5.8% | -177.4% | ||
| Q2 25 | -8.7% | -153.7% | ||
| Q1 25 | -8.6% | -63.8% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 3.9% | -122.0% | ||
| Q2 24 | 6.8% | -203.3% | ||
| Q1 24 | 0.9% | -70.6% |
每股收益（稀释后）CVULAB
| Q4 25 | $0.04 | — | ||
| Q3 25 | $0.09 | $-0.09 | ||
| Q2 25 | $-0.10 | $-0.09 | ||
| Q1 25 | $-0.10 | $-0.07 | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.06 | $-0.07 | ||
| Q2 24 | $0.11 | $-0.12 | ||
| Q1 24 | $0.01 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $25.8M | $399.7M |
| 总资产 | $75.2M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资CVULAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务CVULAB
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $26.5K | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益CVULAB
| Q4 25 | $25.8M | — | ||
| Q3 25 | $25.0M | $399.7M | ||
| Q2 25 | $23.8M | $424.5M | ||
| Q1 25 | $24.9M | $454.6M | ||
| Q4 24 | $25.9M | — | ||
| Q3 24 | $24.9M | $489.3M | ||
| Q2 24 | $24.1M | $510.3M | ||
| Q1 24 | $22.5M | $577.3M |
总资产CVULAB
| Q4 25 | $75.2M | — | ||
| Q3 25 | $74.1M | $539.6M | ||
| Q2 25 | $72.3M | $557.0M | ||
| Q1 25 | $65.4M | $579.6M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $68.9M | $681.5M | ||
| Q2 24 | $70.2M | $708.7M | ||
| Q1 24 | $70.8M | $777.7M |
负债/权益比CVULAB
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.1M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.1M | $-23.1M |
| 自由现金流率自由现金流/营收 | -10.8% | -118.1% |
| 资本支出强度资本支出/营收 | 0.0% | 4.5% |
| 现金转化率经营现金流/净利润 | -3.03× | — |
| 过去12个月自由现金流最近4个季度 | $-5.3M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流CVULAB
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $212.1K | $-22.2M | ||
| Q2 25 | $-596.3K | $-20.7M | ||
| Q1 25 | $-2.7M | $-30.3M | ||
| Q4 24 | $4.4M | — | ||
| Q3 24 | $715.1K | $-27.9M | ||
| Q2 24 | $-591.7K | $-39.0M | ||
| Q1 24 | $-960.5K | $-62.5M |
自由现金流CVULAB
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $211.1K | $-23.1M | ||
| Q2 25 | $-599.8K | $-22.6M | ||
| Q1 25 | $-2.8M | $-35.3M | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $586.9K | $-30.1M | ||
| Q2 24 | $-746.9K | $-41.0M | ||
| Q1 24 | $-1.0M | $-63.3M |
自由现金流率CVULAB
| Q4 25 | -10.8% | — | ||
| Q3 25 | 1.1% | -118.1% | ||
| Q2 25 | -4.0% | -103.6% | ||
| Q1 25 | -18.1% | -86.6% | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 3.0% | -136.4% | ||
| Q2 24 | -3.6% | -182.2% | ||
| Q1 24 | -5.3% | -138.9% |
资本支出强度CVULAB
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 0.0% | 8.7% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.7% | 10.2% | ||
| Q2 24 | 0.7% | 8.6% | ||
| Q1 24 | 0.2% | 1.7% |
现金转化率CVULAB
| Q4 25 | -3.03× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
